Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Low Back Pain and Depression: Cohort Study

16 mai 2014 mis à jour par: Josue Fernandez Carnero, Universidad Rey Juan Carlos

Low Back Pain Disability, Intensity and Widespread Pain and Relationship to Postpartum Depression

The aims of this study are to investigate whether pelvic pain and low back pain disability are associated with postpartum depression and to compare the prevalence between women without Low back pain and disability and women with Low Back Pain (LBP) and disability every trimester, and correlate postpartum Depression and some clinical and biopsychosocial variables: subgroups of LBP, disability, pain intensity, pain widespread and nationality, in a cohort of Spanish women at 2 months postpartum.

Aperçu de l'étude

Statut

Complété

Description détaillée

295 pregnant women will formed the cohort, during all pregnancy and two months after delivery. The Edinburgh Postnatal Depression Scale was used to evaluate depressive symptoms at 2 months postpartum. The LBP will be evaluated based on self-administrated questionnaire, and the patients with LBP will be classified in to lumbopelvic groups according to mechanical assessment of the lumbar spine, pelvic pain provocation tests, standard history, pain intensity on visual analogue scale, spread of pain through pain drawings and Oswestry index was used to evaluated the disability. Logistics regression analysis will performed to explain the predictors of depression.

Type d'étude

Observationnel

Inscription (Réel)

236

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans à 45 ans (Adulte)

Accepte les volontaires sains

Oui

Sexes éligibles pour l'étude

Femelle

Méthode d'échantillonnage

Échantillon non probabiliste

Population étudiée

The cohort comprised all pregnant women who were registered consecutively at this primary health care center

La description

Inclusion Criteria:

  • Inclusion criteria were being pregnant between for 12 weeks to 16 weeks,
  • With an expected normal pregnancy (as determined by midwife),
  • Being able to understand and read Spanish.

Exclusion Criteria:

  • Exclusion criteria were end of pregnancy before gestational weeks 37 (delivery or abortion),
  • Serious intellectual impairment,
  • Having had a systemic disease (spondylitis, infectious, vascular, metabolic or endocrine related process), rheumatic disease, fibromyalgia, lumbopelvic pain or
  • Verified diagnosis of spinal problems in the previous 6 months, or
  • A history of fracture, neoplasm or previous spinal, pelvic or femur surgery.
  • Another exclusion criterion was a diagnosis of depression or anxiety in the previous year.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Post-Partum Depression
Délai: change from baseline in postpartum depression at 2 months after delivery
Depressive Symptoms is assessed through the Edinburgh Postnatal Depression Scale (EPDS) (translation - Spanish). It´s a 10-item self-report scale specifically designed to screen for postpartum depression. The scale rates the intensity of depressive symptoms present within the previous 7 days. A cutoff score of ≥10 in the tests is to be used for screening purposes in primary care. When selecting this threshold the sensitivity for detection of major depression increased to almost 100% and the specificity to 82%. The participants filled it in at the first visit and two months postpartum.
change from baseline in postpartum depression at 2 months after delivery

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Pain Scores in the visual analogue scale
Délai: Participants will be followed for the duration of pregnant up to 36 weeks
The Visual Analog Scale (VAS) is used to assess pain intensity (0-100 mm, where "0" corresponded to "no pain" and "10" to the worst imaginable pain).All participants were evaluated during all their pregnancy: in the first trimester (for 12 to 16 weeks), in the second trimester (for 22 weeks) and in the third trimester (for 36 weeks)
Participants will be followed for the duration of pregnant up to 36 weeks
Low back pain disability
Délai: Participants will be followed for the duration of pregnant up to 36 weeks
Disability is measured with the Oswestry Low Back Pain and Disability Questionnaire (ODQ) to compare the prevalence between women without LBP and disability and women with LBP pain and disability every trimester. All participants were evaluated of low back disability during all their pregnancy: in the first trimester (for 12 to 16 weeks), in the second trimester (for 22 weeks) and in the third trimester (for 36 weeks).
Participants will be followed for the duration of pregnant up to 36 weeks
Pain drawing area
Délai: Participants will be followed for the duration of pregnant up to 36 weeks
Participants completed detailed pain drawings representing a human body (American Academy in Physical Medicine and Rehabilitation. 2001) to assess pain location (lumbar, pelvic and symphysis pubis). To score the spread of pain, these human body views are uniformly divided into a total of 220 squares, each measuring 0.5 x 0.5 cm. .
Participants will be followed for the duration of pregnant up to 36 weeks

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude

1 octobre 2011

Achèvement primaire (Réel)

1 février 2014

Achèvement de l'étude (Réel)

1 mai 2014

Dates d'inscription aux études

Première soumission

7 mai 2014

Première soumission répondant aux critères de contrôle qualité

16 mai 2014

Première publication (Estimation)

20 mai 2014

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Estimation)

20 mai 2014

Dernière mise à jour soumise répondant aux critères de contrôle qualité

16 mai 2014

Dernière vérification

1 mai 2014

Plus d'information

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner